roypounder.apt Profile
roypounder.apt

@APandT

Followers
3K
Following
23
Media
778
Statuses
3K

@APandT new papers in AP&T, summaries free-to-view. 2023 Impact Factor is 6.6, ranking AP&T 18/97 for journals in Gastroenterology & Hepatology.

Joined November 2012
Don't wanna be here? Send us removal request.
@APandT
roypounder.apt
4 days
"Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono-Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study" available to read via #livertwitter #HepB #livertransplant
Tweet media one
0
3
4
@APandT
roypounder.apt
4 days
Read "Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis" open access via #livertwitter #portalhypertension #AIH
Tweet media one
1
8
18
@grok
Grok
22 days
The most fun image & video creation tool in the world is here. Try it for free in the Grok App.
0
199
1K
@APandT
roypounder.apt
12 days
"Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction–Associated Steatotic Liver Disease" available to read via #livertwitter #MASLD
Tweet media one
0
11
22
@APandT
roypounder.apt
20 days
"MetALD: Diagnosis and Prognosis With Non-Invasive Tests" by Torp et al. Read 'open access' via #livertwitter #MetALD
Tweet media one
0
14
16
@APandT
roypounder.apt
20 days
Read 'open access' the systematic review by Manning et al via #GItwitter #microbiome
Tweet media one
0
2
3
@APandT
roypounder.apt
20 days
"Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment" available to read 'open access' via #livertwitter #CHB
Tweet media one
0
4
4
@APandT
roypounder.apt
25 days
Read: "Efficacy and Safety of Vedolizumab and Tofacitinib (VETO) Combination Therapy in Refractory Ulcerative Colitis Unresponsive to Anti-TNF and a Second-Line Advanced Therapy: A Prospective Cohort Nested Within a Randomised Trial" via #IBD #GItwitter
Tweet media one
0
13
48
@APandT
roypounder.apt
1 month
Read 'open access' via "Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non-Acute Decompensation".#livertwitter #cirrhosis #ascites
Tweet media one
0
6
11
@APandT
roypounder.apt
1 month
"Network Meta-Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease" available to read via #GItwitter #IBD #metaanalysis #Crohnsdisease
Tweet media one
0
6
15
@APandT
roypounder.apt
1 month
"Appendectomy Is Not Associated With a Milder Clinical Course of Ulcerative Colitis: A Nationwide Danish Population-Based Study" - available to read 'open access' via #GItwitter #ulcerativecolitis #IBD
Tweet media one
0
12
32
@APandT
roypounder.apt
1 month
Patients with colon cancer and inflammatory bowel disease experience worse overall survival compared to colon cancer patients without inflammatory bowel disease, after adjustments for covariates. Read the full paper via #GItwitter #coloncancer #IBD
Tweet media one
0
6
24
@APandT
roypounder.apt
1 month
Read 'open access' via "Clinical and Genetic Associations in Cephalosporin-Induced Liver Injury: Insights From the Drug-Induced Liver Injury Network" by Vuppalanchi R, et al.#livertwitter #DILI
Tweet media one
0
3
1
@APandT
roypounder.apt
1 month
"Diagnostics of Autoimmune Hepatitis Enabled by Non-Invasive Clinical Proteomics" available to read open access via #Livertwitter #MASLD #AIH
Tweet media one
0
5
7
@APandT
roypounder.apt
2 months
Read 'open access' the 4-year results from the phase 3 UNIFI study of ustekinumab in ulcerative colitis by Danese S, et al via #GItwitter #ulcerativecolitis #clinicaltrial
Tweet media one
0
3
10
@APandT
roypounder.apt
2 months
Read 'open access' via the Research Communication entitled: "Prevalence of Asymptomatic Premalignant Oesophageal Lesions in Patients With Fanconi Anaemia". #GItwitter #oesophagus #fanconianaemia
Tweet media one
0
2
2
@APandT
roypounder.apt
2 months
Analysis of real-world medication prescribing to 5,190 people with metabolic liver disease shows that 1.1% of people take no medications and 75% are prescribed 10 or more medications. Available to read via #livertwitter #polypharmacy #MASLD
Tweet media one
0
4
7
@APandT
roypounder.apt
2 months
Read 'open access' via "Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation"
Tweet media one
1
8
17
@APandT
roypounder.apt
2 months
The "Research Communication: Reflux Disease May Constitute a Risk Factor for Colonic Neoplasia" by Sonnenberg et al is now available to read via #GItwitter #oesophagus #refluxdisease #colonicneoplasia
Tweet media one
0
3
3
@APandT
roypounder.apt
2 months
A practical guide to the use of therapies in inflammatory bowel disease in the setting of chronic kidney disease. Read (open access) the guidance via #IBD #GItwitter #CKD
Tweet media one
0
17
37